Repair of fungal aortic prosthetic valve endocarditis associated with periannular abscess
Related Experiment Video
Updated: Sep 3, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
1State University of New York, Health Science Center at Brooklyn, New York, USA.
Abstract:
The incidence of prosthetic valve endocarditis is 2-4%; in most cases the involved organisms are Staphylococcus epidermidis and Staph. aureus. Fungal endocarditis is much less common (incidence < 0.1%), but it is often fatal, with a long-term mortality rate of 90-100%. Most fungal endocarditis cases occur after aortic valvular surgery, due to Candida sp. Late-onset symptoms, long-term development and aggressive nature of the fungus makes its eradication complicated and treatment difficult. Fungal valvular mycoses produce systemic embolization and cause serious perioperative bleeding on resection of infected tissue. Usually surgery includes aortic root replacement with an aortic homograft conduit after radical debridement, to attain local sterilization. This report describes a patient with complex infection, requiring replacement of an infected prosthetic valve with an aortic homograft conduit, aggressive and radical debridement of infected tissue, and reconstruction using biologic tissues. The case demonstrates the importance of perioperative and long-term antifungal treatment and presents a modified 'Cabrol procedure' to prevent critical intraoperative hemorrhage.
Insights
Fungal endocarditis, though rare, has a high mortality rate. This case highlights successful surgical and antifungal treatment for a complex fungal prosthetic valve infection.
Area of Science:
- Cardiology
- Infectious Diseases
- Surgical Innovation
Background:
- Prosthetic valve endocarditis (PVE) affects 2-4% of patients, typically caused by Staphylococcus species.
- Fungal endocarditis (FE) is rare (<0.1%) but carries a grim prognosis with 90-100% long-term mortality.
- Candida species are the most common culprits in FE, often occurring post-aortic valve surgery.
Observation:
- Fungal valvular mycoses present diagnostic and therapeutic challenges due to late onset, aggressive fungal nature, systemic embolization, and severe bleeding risks.
- This case involved a complex prosthetic valve infection requiring extensive surgical intervention.
- The patient underwent prosthetic valve replacement with an aortic homograft conduit, radical debridement, and reconstruction with biologic tissues.
Findings:
- The successful management involved a modified 'Cabrol procedure' to control intraoperative hemorrhage.
- Aggressive surgical debridement and reconstruction were crucial for local sterilization.
- Perioperative and long-term antifungal therapy were essential components of the treatment strategy.
Implications:
- This case underscores the critical role of comprehensive antifungal treatment in managing fungal prosthetic valve endocarditis.
- Surgical techniques like the modified 'Cabrol procedure' can be vital for managing bleeding complications.
- Effective treatment necessitates a multidisciplinary approach combining surgical expertise and prolonged antifungal therapy.
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation I: Introduction
Endocarditis IV: Nursing Management
Aneurysm III: Interprofessional Care

